Skip to content
More than 400 biotech leaders, including many Biotechnology Innovation Organization (BIO) members, have signed a statement condemning Friday’s ruling in a Texas federal court […]
BIO members, chair among 400 biotech leaders opposing Texas ruling Read More »
On Friday, U.S. District Judge Matthew Kacsmaryk in Amarillo, Texas, ordered a hold on federal approval of mifepristone, a drug approved by the U.S.
Texas mifepristone ruling undermines FDA approval process, experts say Read More »
On April 7, 1948—75 years ago—the World Health Organization (WHO) Constitution came into force, launching the global health body that had been planned during
Today’s World Health Day puts a focus on equity Read More »
Orphan drugs are the fastest-growing segment of the pharmaceutical market, but the Inflation Reduction Act (IRA) clouds the future of new treatments for rare
Report sees booming orphan drug market threatened by price controls Read More »
The World Vaccine Congress 2023 convened in Washington, D.C., from April 3-6 to discuss a host of issues affecting vaccine uptake and infrastructure. Emily Acker,
World Vaccine Congress addresses vaccine hesitancy, infrastructure, policy Read More »
Polls conducted by YouGov and Wakefield Research show the majority of Americans want the government to invest in better pandemic preparedness in the wake
Polls show Americans want better pandemic preparedness Read More »
On April 3, the Biden administration released a National Cancer Plan that seeks to coordinate government, research, and the biotech industry to cut cancer deaths
National Cancer Plan outlines government cooperation with biotech industry Read More »
Scientists using the CRISPR-Cas9 gene-editing technology say they can treat mice to reverse the deterioration that takes place after a heart attack. Their research
CRISPR post-heart attack therapy suggests new uses for gene editing Read More »
The “benefits” pharmacy benefit managers (PBMs) once provided have been lost, as these organizations now mostly help themselves while driving up drug prices, said
Senate hearing looks at what went wrong with PBMs Read More »
The threat of expanding intellectual property waivers by the World Trade Organization (WTO) dampens investment in research, Biotechnology Innovation Organization’s (BIO) Chief Policy Officer
BIO opposes extension of WTO IP waiver in federal hearing Read More »
